Comparing radiation margins for brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests two different radiation margins (how much healthy tissue is included around a brain tumor) during a single treatment session. It aims to see which margin is better at controlling brain metastases while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years or older.
- You have brain metastases that have not been treated before.
- Each tumor must be 4 cm or smaller.
- You must not be pregnant or planning to become pregnant.
- You must be able to have an MRI scan.
- You must not have had radiation to the same brain tumor before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving targeted radiation while surgeons are operating to treat brain metastases. It may help control the cancer locally at the time of surgery, especially for certain single lesions.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
This trial tests a new pattern of high-precision radiation (given over 3 days instead of 5) for people with a limited number of brain tumors from hard-to-treat cancers like melanoma or kidney cancer. The goal is to see if a shorter treatment schedule is just as effective and easier for patients.
This Phase 1 study tests how to safely give focused radiation (SRS) at different doses to people with brain metastases. It aims to find a dose level that works well while limiting side effects.
This study tests a targeted radiation treatment for brain tumors that have spread from lung cancer and may not have responded to other treatments. The goal is to see if this precise radiation approach can shrink these tumors and improve survival with fewer side effects.
Hear when a new Brain Metastases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.